Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen
Shivaprasad Manjappa, Rizwan Romee(Harvard University), Srinidhi J. Meera(Washington University in St. Louis), Ravi Vij(Washington University in St. Louis), Amanda F. Cashen(Washington University in St. Louis), Iskra Pusic(Washington University in St. Louis), John F. DiPersio(Washington University in St. Louis), Pavan Kumar Bhamidipati, Camille N. Abboud(Washington University in St. Louis), Keith Stockerl‐Goldstein(City Of Hope National Medical Center), Mark A. Schroeder(MACOM (United States)), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Peter Westervelt(MACOM (United States)), Todd A. Fehniger(Washington University in St. Louis), Meagan A. Jacoby(MACOM (United States)), Jingxia Liu(Washington University in St. Louis)
Cited by 97
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
|Immunity|2007|988
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783